Novo’s Chief to Retire, Veteran Joergensen to Succeed Him

  • Joergensen to take over Jan. 1 after 25 years at the company
  • Soerensen will get nominated for seat on Novo A/S board

Novo Nordisk Names Joergensen CEO as Sorensen Retires

Novo Nordisk A/S, the world’s biggest maker of insulin, said Chief Executive Officer Lars Rebien Soerensen will retire by the end of 2016, unexpectedly early, after 16 years at the helm.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.